Intranuclear localization of the transcription coadaptor CBP/p300 and the transcription factor RBP-Jk in relation to EBNA-2 and -5 in B lymphocytes

Virology

Volumn 288, Issue 2, 2001, Pages 275-282

  Bandobashi, Kentaro ^a,b   Maeda, Akihiko ^a,b   Teramoto, Norihiro ^a,c   Nagy, Noémi ^a   Székely, László ^a   Taguchi, Hirokuni ^b   Miyoshi, Isao ^b   Klein, George ^a   Klein, Eva ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

CBP; EBNA 2; EBNA 5; EBV; p300; PML bodies; RBP Jk

Indexed keywords

ADAPTOR PROTEIN; CD40 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN EBNA 2; PROTEIN EBNA 5; PROTEIN P300; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RBP JK; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0035975611     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1103     Document Type: Article

References (31)

1. Early events in Epstein-Barr virus infection of human B lymphocytes
2. Intracellufar localization of proteasomal degradation of a viral antigen
3. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein
4. The CBP co-activator is a histone acetyltransferase
5. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro
6. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines
7. CBR/p300 in cell growth, transformation, and development
8. Biochemical and immunological characterization of the DNA binding protein (RBR-J kappa) to mouse J kappa recombination signal sequence
9. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation
10. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa
11. Computer programs that allow fast acquisition, visualization and overlap quantitation of fluorescent 3D microscopic objects by using nearest-neighbor deconvolution algorithm
12. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2
13. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex
14. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays
15. Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors
16. Co-locaLization of the retinobtastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5
17. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1
18. The proto-encogene c-myc is a direct target gene of Epstein-Bart virus nuclear antigen 2
19. Localization of nascent RNA and CREB binding protein with the PMLcontaining nuclear body
20. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein
21. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation
22. Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: A role for the W1W2 repeat domain
23. Epstein-Barr virus
24. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein
25. EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus
26. Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 and hsp70 proteins after exposure to heat shock or cell density congestion
27. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies
28. Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle
29. CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus
30. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter
31. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection